Jenn's Story of Managing MCAS, EDS and POTS episode artwork

EPISODE · Feb 26, 2025 · 24 MIN

Jenn's Story of Managing MCAS, EDS and POTS

from The LDN Radio Show About Low Dose Naltrexone

Jenn from Canada shared her experience with mast cell activation syndrome (MCAS) and Ehlers-Danlos syndrome (EDS). She described experiencing symptoms of disautonomia and dislocations from a young age. Her health challenges worsened during her teen years with symptoms such as mold exposure, recurrent hospitalizations for mystery illnesses, and autoimmune-related issues. It wasn't until two years ago that she was diagnosed with MCAS after discovering hidden mold in her home. After consulting with an allergist and starting on a personalized treatment cocktail, including low-dose naltrexone (LDN), she noticed improvements in her chronic headaches, sleep, and other symptoms. The LDN helped alleviate her symptoms more than she expected and significantly improved her quality of life.

Episode metadata supplied by the publisher feed · Published Feb 26, 2025

Embed this episode

NOW PLAYING

Jenn's Story of Managing MCAS, EDS and POTS

0:00 24:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The LDN Radio Show About Low Dose Naltrexone?

This episode is 24 minutes long.

When was this The LDN Radio Show About Low Dose Naltrexone episode published?

This episode was published on February 26, 2025.

Can I download this The LDN Radio Show About Low Dose Naltrexone episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!